Redefining Enablement: The Impact of Amgen v. Sanofi on Patent Law and Biotechnology

In this article, Lana El-Etr examines how the Amgen v. Sanofi ruling strengthens the enablement requirement, limiting overly broad genus claims while promoting innovation and ensuring accessibility to scientific advancements. She explores the broader implications of the decision, arguing that it strikes a necessary balance between protecting genuine innovation and preventing monopolies on vaguely defined scientific concepts.

The E-SIGN Act in the Age of Smart Contracts and AI: Challenges and Opportunities

In this article, Porter Richards examines whether the current state of the E-SIGN Act is viable in the age of smart contracts. He argues that while the E-SIGN Act ensures enforceability and consumer protections, emerging smart contracts, and AI-driven agreements challenge its applicability. As these technologies evolve, legal updates may be needed to address consent, transparency, and enforcement in automated digital contracts.

Blog at WordPress.com.

Up ↑